Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This is a Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma.
Epistemonikos ID: b56119b742d5bd54291e08bd280e5b381a7ad803
First added on: May 06, 2024